{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-033059","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.656257+00:00","generated_at":"2026-06-10T13:30:52.896133+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sigyn Therapeutics amends convertible notes: extends maturity to Aug 2024, increases principal","bullets":["Entered amendment agreements for $2,161,316 of convertible notes, extending maturity to August 30, 2024.","Principal increased to reflect implied 12% interest rate from amendment date through new maturity.","Upon national exchange listing, notes automatically convert into Series A Convertible Preferred Stock.","Company expects to enter similar amendments with remaining holders of $3,051,516 principal notes (as of June 30, 2023)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-033059","json":"https://secwatch.observer/filing/0001493152-23-033059.json","markdown":"https://secwatch.observer/filing/0001493152-23-033059.md","text":"https://secwatch.observer/filing/0001493152-23-033059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/0001493152-23-033059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T13:30:52.896133+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6fb77fb2974e72b982b309eb350a74b95be67fc2","claim":"Sigyn Therapeutics, Inc. amended Amendment Agreement with certain accredited investors valued at $2,161,316 principal amount (effective 2023-09-14).","evidence_excerpt":"On September 14, 2023, the Company entered into Amendment Agreements with $2,161,316 principal amount of these notes to extend the maturity date to August 30, 2024.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/0001493152-23-033059-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$2,161,316 principal amount"},{"label":"Effective","value":"2023-09-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}